• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

4-Methylaminoethylpyridine Dihydrochloride: A Comprehensive Overview

4-Methylaminoethylpyridine dihydrochloride, also known by its CAS number 101252-40-8, is a chemical compound that has garnered significant attention in the fields of pharmacology and organic chemistry. This compound is a derivative of pyridine, a six-membered aromatic heterocycle, and contains a methylaminoethyl substituent at the 4-position. The dihydrochloride form indicates that the compound exists as a salt with two hydrochloric acid molecules. This compound is widely studied for its potential applications in drug development, particularly in the design of bioactive molecules with specific pharmacological properties.

The structural elucidation of 4-methylaminoethylpyridine dihydrochloride has been a focal point in recent studies. Researchers have employed advanced spectroscopic techniques, such as nuclear magnetic resonance (NMR) and mass spectrometry, to confirm its molecular structure. The compound's unique arrangement of functional groups—namely the pyridine ring, the aminoethyl chain, and the methyl group—contributes to its distinctive chemical reactivity and biological activity. These studies have been instrumental in understanding the compound's behavior in various chemical environments and its potential interactions with biological systems.

One of the most promising areas of research involving 4-methylaminoethylpyridine dihydrochloride is its application in medicinal chemistry. Scientists have explored its ability to act as a scaffold for drug design, particularly in the development of kinase inhibitors and other enzyme-targeting agents. Recent findings suggest that this compound exhibits moderate inhibitory activity against certain protein kinases, making it a valuable lead compound for further optimization. Additionally, its structural flexibility allows for easy modification, enabling researchers to tailor its properties for specific therapeutic applications.

The synthesis of 4-methylaminoethylpyridine dihydrochloride has also been a subject of extensive investigation. Traditional methods involve multi-step reactions, including nucleophilic substitution and acid-base neutralization. However, recent advancements have introduced more efficient synthetic routes, such as one-pot reactions and microwave-assisted synthesis, which significantly reduce reaction times and improve yields. These innovations not only enhance the scalability of production but also contribute to cost-effective manufacturing processes.

In terms of pharmacokinetics, studies on 4-methylaminoethylpyridine dihydrochloride have revealed interesting insights into its absorption, distribution, metabolism, and excretion (ADME) properties. Preclinical trials indicate that the compound demonstrates moderate bioavailability when administered orally, with a relatively long half-life due to its lipophilic nature. These characteristics make it an attractive candidate for chronic disease treatments where sustained drug levels are desirable.

The safety profile of 4-methylaminoethylpyridine dihydrochloride has also been evaluated in various toxicity studies. Acute and chronic toxicity tests in animal models suggest that the compound exhibits low toxicity at therapeutic doses. However, further long-term studies are required to fully assess its safety profile and potential for human use.

In conclusion, 4-methylaminoethylpyridine dihydrochloride, with its unique chemical structure and promising biological properties, represents a significant advancement in the field of medicinal chemistry. Its potential applications span across various therapeutic areas, from oncology to neurodegenerative diseases. As research continues to uncover new insights into its mechanisms of action and pharmacological properties, this compound is poised to play a pivotal role in the development of novel therapeutic agents.

• 55496-55-4(methyl2-(pyridin-4-yl)ethylamine)
• 38223-06-2(4-Pyridineethanamine,N,N-dimethyl-)
• 775288-43-2(Pyridine,4-[2-(1-azetidinyl)ethyl]-)
• 775288-44-3(4-Pyridineethanamine,N-ethyl-N-methyl-)
• 89151-21-3(1,3-Propanediamine, N-ethyl-N'-[2-(4-pyridinyl)ethyl]-)
• 13258-63-4(2-(pyridin-4-yl)ethan-1-amine)
• 67580-61-4(diethyl2-(pyridin-4-yl)ethylamine)
• 17039-03-1(4-Pyridineethanamine,hydrochloride (1:2))
• 89151-20-2(1,2-Ethanediamine, N-[2-(4-pyridinyl)ethyl]-)
• 6429-12-5(2-(Pyridin-4-yl)ethanamine hydrochloride)